ERNEST HAWK to Risk Factors
This is a "connection" page, showing publications ERNEST HAWK has written about Risk Factors.
Connection Strength
0.250
-
Cancer prevention in developing countries: a vision for preserving health in Mexico. Salud Publica Mex. 2016 Apr; 58(2):93-6.
Score: 0.040
-
Do statins prevent cancer? Nat Clin Pract Oncol. 2006 Sep; 3(9):478-9.
Score: 0.021
-
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
Score: 0.017
-
Chemoprevention of colorectal cancer: problems, progress, and prospects. Gastroenterol Clin North Am. 2002 Dec; 31(4):971-99.
Score: 0.016
-
Epidemiology and prevention of colorectal cancer. Surg Clin North Am. 2002 Oct; 82(5):905-41.
Score: 0.016
-
Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev. 2021 09; 30(9):1643-1651.
Score: 0.014
-
Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):523-7.
Score: 0.013
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.013
-
Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):486-494.
Score: 0.012
-
Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 2018 07 01; 32(13-14):868-902.
Score: 0.012
-
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
Score: 0.009
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
Score: 0.008
-
Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J Natl Cancer Inst. 2012 Oct 17; 104(20):1599-611.
Score: 0.008
-
Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk. Int J Cancer. 2012 Oct 15; 131(8):1892-903.
Score: 0.008
-
Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):415-6.
Score: 0.007
-
Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res (Phila). 2010 Apr; 3(4):505-17.
Score: 0.007
-
A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009 May; 7(5):568-74.
Score: 0.006
-
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 2008 Apr 22; 117(16):2104-13.
Score: 0.006
-
Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res. 2006 Jul 01; 66(13):6851-60.
Score: 0.005
-
Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51.
Score: 0.004
-
Adenocarcinoma of the esophagus: risk factors and prevention. Oncology (Williston Park). 2000 Apr; 14(4):507-14; discussion 518-20, 522-3.
Score: 0.003
-
Perspectives and progress in development of breast cancer chemopreventive drugs. Prog Clin Biol Res. 1997; 396:159-83.
Score: 0.003
-
Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl. 1996; 25:1-14.
Score: 0.002